81 related articles for article (PubMed ID: 2575676)
1. [Close correlation between restriction fragment length polymorphism of the L-myc gene and metastasis of lung cancer and prognosis].
Kawashima K; Nishimura S
Rinsho Byori; 1989 Jul; (Spec No 82):29-34. PubMed ID: 2575676
[No Abstract] [Full Text] [Related]
2. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
3. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs.
Kawashima K; Shikama H; Imoto K; Izawa M; Naruke T; Okabayashi K; Nishimura S
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2353-6. PubMed ID: 2895475
[TBL] [Abstract][Full Text] [Related]
4. [Studies on genes associated with biologic behavior in human lung cancer].
Bai L; Sun Y; Li S
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):23-5. PubMed ID: 11263295
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
6. Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients.
Ejarque MJ; Vicente M; Bernués M; Oliver A; Vicente J; Capellá G; Lluís F; Chéchile G
Br J Cancer; 1999 Apr; 79(11-12):1855-8. PubMed ID: 10206304
[TBL] [Abstract][Full Text] [Related]
7. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
8. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
10. Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.
Kawashima K; Nomura S; Hirai H; Fukushi S; Karube T; Takeuchi K; Naruke T; Nishimura S
Int J Cancer; 1992 Feb; 50(4):557-61. PubMed ID: 1347036
[TBL] [Abstract][Full Text] [Related]
11. A case of pleomorphic adenoma of the lung with multiple distant metastases--observations on its oncogene and tumor suppressor gene expression.
Takeuchi E; Shimizu E; Sano N; Yamaguchi T; Yanagawa H; Sone S
Anticancer Res; 1998; 18(3B):2015 -20. PubMed ID: 9677459
[TBL] [Abstract][Full Text] [Related]
12. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
13. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
[TBL] [Abstract][Full Text] [Related]
14. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
Tefre T; Børresen AL; Aamdal S; Brøgger A
Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis suggests association of L-myc EcoRI polymorphism with cancer prognosis.
Spinola M; Pedotti P; Dragani TA; Taioli E
Clin Cancer Res; 2004 Jul; 10(14):4769-75. PubMed ID: 15269151
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
Saksela K; Bergh J; Nilsson K
J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
[TBL] [Abstract][Full Text] [Related]
18. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?].
Osaki T; Oyama T; Takenoyama M; Taga S; So T; Yamashita T; Nakata S; Sugio K; Yasumoto K
Kyobu Geka; 2002 Jan; 55(1):25-9. PubMed ID: 11797404
[TBL] [Abstract][Full Text] [Related]
20. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
